Catheter Precision, Inc. Receives First Purchase Order for VIVO from Middle East Distributor

FORT MILL, SC / ACCESSWIRE / June 20, 2024 / Catheter Precision, Inc. (NYSE American:VTAK), a US-based innovative medical device company, announced the receipt of its first purchase order from Qatar. An initial evaluation of the VIVO product was completed earlier this year at Hamad Medical Corporation Heart Hospital in Doha.

"VIVO is a tool that allows physicians to streamline ventricular ablation procedures potentially saving time and reducing patient complications," said Fatih Ayoglu, European Sales Manager. "We look forward to continuing this expansion strategy."

Catheter Precision's VIVO™ (View Into Ventricular Onset) is a non-invasive 3D imaging system that enables physicians to identify the origin of ventricular arrhythmias pre-procedure. This streamlines workflow and reduces procedure time. VIVO has received marketing clearance from the U.S. FDA and holds the CE mark.